- Home
- BCTX vs AACG Comparison
BCTX vs AACG Comparison
Compare BCTX & AACG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCTX
- AACG
- Stock Information
- Founded
- BCTX 2014
- AACG 1999
- Country
- BCTX Canada
- AACG China
- Employees
- BCTX N/A
- AACG N/A
- Industry
- BCTX Biotechnology: Pharmaceutical Preparations
- AACG Other Consumer Services
- Sector
- BCTX Health Care
- AACG Real Estate
- Exchange
- BCTX Nasdaq
- AACG Nasdaq
- Market Cap
- BCTX 34.6M
- AACG 31.9M
- IPO Year
- BCTX N/A
- AACG N/A
- Fundamental
- Price
- BCTX $0.41
- AACG $0.89
- Analyst Decision
- BCTX Strong Buy
- AACG
- Analyst Count
- BCTX 1
- AACG 0
- Target Price
- BCTX $15.00
- AACG N/A
- AVG Volume (30 Days)
- BCTX 977.6K
- AACG 22.8K
- Earning Date
- BCTX 03-17-2025
- AACG 11-07-2024
- Dividend Yield
- BCTX N/A
- AACG N/A
- EPS Growth
- BCTX N/A
- AACG N/A
- EPS
- BCTX N/A
- AACG N/A
- Revenue
- BCTX N/A
- AACG $35,747,843.00
- Revenue This Year
- BCTX N/A
- AACG N/A
- Revenue Next Year
- BCTX N/A
- AACG N/A
- P/E Ratio
- BCTX N/A
- AACG N/A
- Revenue Growth
- BCTX N/A
- AACG 15.80
- 52 Week Low
- BCTX $0.37
- AACG $0.50
- 52 Week High
- BCTX $4.37
- AACG $1.65
- Technical
- Relative Strength Index (RSI)
- BCTX 36.36
- AACG 46.44
- Support Level
- BCTX $0.38
- AACG $0.92
- Resistance Level
- BCTX $0.42
- AACG $1.02
- Average True Range (ATR)
- BCTX 0.05
- AACG 0.07
- MACD
- BCTX 0.00
- AACG 0.00
- Stochastic Oscillator
- BCTX 12.86
- AACG 34.26
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
About AACG ATA Creativity Global
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments are Overseas art study services, Other educational services and K-12 education assessment and other services. Majority of its revenue comes from Overseas art study services.